Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Frederick, Maryland
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 873 filings
- On EDGAR
- CIK 1453687
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 42
News 8 of 174
- 8-K Quarterly results Aug 6, 2026
- 8-K Shareholder vote results Jun 17, 2026
- 8-K Current report on a material event Jun 9, 2026
- 8-K Leadership change May 26, 2026
- 8-K Quarterly results Apr 30, 2026
- 8-K Leadership change Mar 30, 2026
- 8-K Quarterly results Mar 9, 2026
- 8-K Current report on a material event Jan 9, 2026
Prospectuses and Registrations 8 of 36
- S-8 Registration statement for an employee plan Apr 30, 2026
- S-8 Registration statement for an employee plan May 8, 2025
- POS AM Post-effective amendment to a registration Jan 10, 2025
- POS AM Post-effective amendment to a registration Jan 10, 2025
- 424B3 Prospectus supplement for an offering Jan 8, 2025
- S-3 Shelf registration statement Dec 13, 2024
- S-3 Shelf registration statement Dec 13, 2024
- S-3 Shelf registration statement Dec 13, 2024
Proxies 8 of 31
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Aug 16, 2024
- PRE 14A Preliminary proxy statement Aug 2, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 26, 2024
Ownership 8 of 507
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 22, 2026
- 144 Notice of a proposed sale of restricted stock Jun 9, 2026
- 144 Notice of a proposed sale of restricted stock Jun 2, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 6, 2026
- 4 Insider reported a trade Apr 6, 2026
- 4 Insider reported a trade Apr 6, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Apr 2, 2026
Other 8 of 83
- EFFECT Notice that a registration became effective Jan 13, 2025
- EFFECT Notice that a registration became effective Jan 13, 2025
- EFFECT Notice that a registration became effective Jan 8, 2025
- EFFECT Notice that a registration became effective Jan 8, 2025
- EFFECT Notice that a registration became effective Jan 8, 2025
- 424B7 Jan 8, 2025
- 424B7 Jan 8, 2025
- CORRESP Reply to SEC staff Jan 6, 2025
Everything here comes from Cartesian Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.